KELSEYVILLE, CA, Feb. 16, 2018 -- Vet Online Supply, Inc. (OTC PINK: VTNL) (the Company), announces today a share buyback and dividend program for 2018.
Dan Rushford, CEO, stated, “Our recent purchase orders for January and February 2018 of $529,790 and $245,000 have allowed our Company to start the process to purchase-back shares of the company in order to focus on anti-dilution measures, stock price increases and minimizing the number of shareholders as we target the New York Stock Exchange listing procedures. We are designing a program to provide prorated dividends to our shareholders. Dividend stocks are inflation resistant because as prices rise the profits of a company rise as well. Dividends are based off company profits, and we want our shareholders to benefit and support Vet Online Supply. We are approaching our revenue target sooner than anticipated, and this will assist us in expediting our plan, according to management.”
The company received its first retail order from a major CBD retailer on December 13, 2017 for the purchase of 5,000 units of the CBD Pet Treats and CBD Pet Drops for approximately $245,000, and another purchase order of $529,790 for 10,000 units of our CBD Pet Drops and 7,000 units of our CBD Pet Supplement Treats.
The company will announce another new private label of its new Pet Performance Product in February 2018. Projected earnings for the Pet Performance Product in 2018 are $1.3M.
The company will announce another new breeding franchise in February 2018. Projected earnings for the breeding franchise in 2018 are $1.1M. The breeding franchise business model integrates the Pet Products on a national scale.
ABOUT VET ONLINE SUPPLY:
Vet Online Supply Inc. is a small US based online retail reseller of proprietary veterinary products. The goal of "Vet Online Supply" is to provide the $38B industry with value priced, superior quality products.
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The Company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
Contact: Meridian Consulting 323-364-3793


Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Samsung Electronics Shares Jump on HBM4 Mass Production Report
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Anta Sports Expands Global Footprint With Strategic Puma Stake 



